The role of human papillomavirus testing in the management of women with low-grade abnormalities: Multicentre randomised controlled trial

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 117, Issue 6, 2010, Pages 645-659

  Cotton, S ^a   Sharp, L ^b   Little, J ^c   Cruickshank, M ^a   Seth, R ^d   Smart, L ^e   Duncan, I ^f   Harrild, K ^a   Neal, K ^d   Waugh, N ^a  

^a UNIVERSITY OF ABERDEEN   (United Kingdom)

^b NATIONAL CANCER REGISTRY IRELAND   (Ireland)

^c UNIVERSITY OF OTTAWA   (Canada)

^d QUEEN S MEDICAL CENTRE   (United Kingdom)

^e UNIVERSITY OF ABERDEEN   (United Kingdom)

^f UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Borderline nuclear abnormality; Cervical intraepithelial neoplasia; Cervical screening; Colposcopy; Cytological surveillance; Follow up; Human papillomavirus; Low grade abnormalities; Management; Mass screening; Mild dyskaryosis; Randomised controlled trial

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER SCREENING; CLINICAL DECISION MAKING; CLINICAL TRIAL; COLPOSCOPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; DISEASE ASSOCIATION; DISEASE SEVERITY; DYSKARYOSIS; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN CELL; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; MULTICENTER STUDY; PATIENT CARE; POLYMERASE CHAIN REACTION; PREDICTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SENSITIVITY AND SPECIFICITY; TREATMENT PLANNING; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; VIRUS DETECTION; VIRUS EXAMINATION; WART VIRUS;

ADULT; CERVICAL INTRAEPITHELIAL NEOPLASIA; COLPOSCOPY; CROSS-SECTIONAL STUDIES; FEMALE; HUMANS; LONGITUDINAL STUDIES; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS; YOUNG ADULT;

EID: 77950682192     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.2010.02519.x     Document Type: Article

References (59)

1. NHS Scotland, Information & Statistics Division. Cervical Cytology Workload Statistics (Quarter ending 30 September 2003).
2. NHS Cervical Screening Programme. Annual Review 2002: Building on Experience.
3. Raffle AE, Alden B, Quinn M, Babb PJ, Brett MT. Outcomes of screening to prevent cancer: analysis of cumulative incidence of cervical abnormality and modelling of cases and deaths prevented. BMJ 2003 326 : 901 905. (Pubitemid 36528944)
4. TOMBOLA Group. Refining the management of low-grade cervical abnormalities in the UK National Health Service, and defining the potential for HPV testing: a commentary on emerging evidence. J Low Genit Tract Dis 2006 10 : 26 38.
5. IARC Working Group. Cervix Cancer Screening.
6. Bosch FX, Iftner T. The Aetiology of Cervical Cancer.
7. Schiffman M, Castle PE, Jeronimo J, Rodriguez AC, Wacholder S. Human papillomavirus and cervical cancer. Lancet 2007 370 : 890 907. (Pubitemid 47371147)
8. Cuzick J, Sasieni P, Davies P, Adams J, Normand C, Frater A, et al. A systematic review of the role of human papillomavirus testing within a cervical screening programme. Health Technol Assess 1999 1 196. (Pubitemid 29475240)
9. Molden T, Nygard JF, Kraus I, Karlsen F, Nygard M, Skare GB, et al. Predicting CIN2+ when detecting HPV mRNA and DNA by PreTect HPV-proofer and consensus PCR: a 2-year follow-up of women with ASCUS or LSIL pap smear. Int J Cancer 2005 114 : 973 976. (Pubitemid 40504480)
10. Berkhof J, de Bruijne MC, Zielinski GD, Bulkmans NW, Rozendaal L, Snijders PJ, et al. Evaluation of cervical screening strategies with adjunct high-risk human papillomavirus testing for women with borderline or mild dyskaryosis. Int J Cancer 2006 118 : 1759 1768. (Pubitemid 43376440)
11. Ho GYF, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus infection in young women. N Engl J Med 1998 338 : 423 428. (Pubitemid 28135669)
12. Woodman CBJ, Collins S, Winter H, Bailey A, Ellis J, Prior P, et al. Natural history of cervical human papillomavirus infection in young women: a longitudinal cohort study. Lancet 2001 357 : 1831 1836. (Pubitemid 32539115)
13. Nobbenhuis MAE, Meijer CJLM, Van Den Brule AJC, Rozendaal L, Voorhorst FJ, Risse EKJ, et al. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 2001 84 : 796 801. (Pubitemid 32275653)
14. Koutsky L, Kiviat NB. Genital human papillomaviruses. In : Holmes K, Mardh P, Sparling P, Lemon SM, Stamm WE, Piot P, editors. Sexually Transmitted Diseases, 3rd edn.
15. Munoz N, Bosch FX, de Sanjose S, Herrero R, Castellsague X, Shah KV, et al. Epidemiologic classification of human papillomavirus types associated with cervical cancer. N Engl J Med 2003 348 : 518 527. (Pubitemid 36159887)
16. Moss S, Gray A, Legood R, Vessey M, Patnick J, Kitchener H. Effect of testing for human papillomavirus as a triage during screening for cervical cancer: observational before and after study. BMJ 2006 332 : 83 5. (Pubitemid 43099248)
17. Legood R, Gray A, Wolstenholme J, Moss S. Lifetime effects, costs and cost effectiveness of testing for human papillomavirus to manage low grade cytological abnormalities: results of the NHS pilot studies. BMJ 2006 332 : 79 85.
18. NHS Cancer Screening Programmes. HPV Sentinel Sites Implementation Project. 2008. [ http://www.cancerscreening.nhs.uk/cervical/hpv.html#sentinel- sites ]. Accessed 29 January 2008.
19. Arbyn M, Buntix F, Van Ranst M. Triage of women with Atypical or Low-grade Cytological Abnormalities of the Cervix by HPV Testing: Systematic Review and Meta-analysis.
20. Arbyn M, Paraskevaidis E, Martin-Hirsch P, Prendiville W, Dillner J. Clinical utility of HPV-DNA detection: triage of minor cervical lesions, follow-up of women treated for high-grade CIN: an update of pooled evidence. Gynecol Oncol 2005 99 : S7 S11.
21. ALTS Group. Human papillomavirus testing for triage of women with cytologic evidence of low-grade squamous intraepithelial lesions: baseline data from a randomized trial. J Natl Cancer Inst 2000 92 : 397 402.
22. ALTS Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003 188 : 1393 1400.
23. ALTS Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol 2003 188 : 1383 1392.
24. Kulasingam SL, Kim JJ, Lawrence WF, Mandelblatt JS, Myers ER, Schiffman M, et al. Cost-effectiveness analysis based on the atypical squamous cells of undetermined significance/low-grade squamous intraepithelial lesion triage study (ALTS). J Natl Cancer Inst 2006 98 : 92 100.
25. Kitchener HC, Almonte M, Wheeler P, Desai M, Gilham C, Bailey A, et al. HPV testing in routine cervical screening: cross sectional data from the ARTISTIC trial. Br J Cancer 2006 95 : 56 61.
26. Hibbitts S, Rieck GC, Hart K, Powell NG, Beukenholdt R, Dallimore N, et al. Human papillomavirus infection: an anonymous prevalence study in South Wales. Br J Cancer 2006 95 : 226 232.
27. Cotton SC, Sharp L, Seth R, Masson LF, Little J, Cruickshank ME, et al. Lifestyle and socio-demographic factors associated with high-risk HPV infection in UK women. Br J Cancer 2007 97 : 133 139. (Pubitemid 47012084)
28. Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Howard M, et al. Adjunctive human papillomavirus testing in the 2-year follow-up of women with low-grade cervical cytologic abnormalities. Arch Pathol Lab Med 2003 127 : 1169 1175.
29. Solomon D, Schiffman M. Have we resolved how to triage equivocal cervical cytology? J Natl Cancer Inst 2004 96 : 250 251. (Pubitemid 38256261)
30. Rebello G, Hallam N, Smart G, Farquharson D, McCafferty J. Human papillomavirus testing and the management of women with mildly abnormal cervical smears: an observational study. BMJ 2001 322 : 893 894. (Pubitemid 32324310)
31. Manos MM. HPV testing for clarifying borderline cervical smear results. BMJ 2001 322 : 878 879.
32. Lytwyn A, Sellors JW, Mahony JB, Daya D, Chapman W, Ellis N, et al. Comparison of human papillomavirus DNA testing and repeat papanicolaou test in women with low-grade cervical cytologic abnormalities: a randomized trial. Can Med Assoc J 2000 163 : 701 707.
33. Cuzick J, Szarewski A, Cubie H, Hulman G, Kitchener H, Luesley D, et al. Management of women who test positive for high-risk types of human papillomavirus: The HART study. Lancet 2003 362 : 1871 1876. (Pubitemid 37518501)
34. Kucera E, Sliutz G, Czerwenka K, Breitenecker G, Leodolter S, Reinthaller A. Is high-risk human papillomavirus infection associated with cervical intraepithelial neoplasia eliminated after conization by large-loop excision of the transformation zone? Eur J Obstet Gynecol Reprod Biol 2001 100 : 72 6. (Pubitemid 33124276)
35. Mann CH, Steele JC, Burton A, Bailey AS, Etherington IJ, Luesley DM. LLETZ - evidence of its efficacy against HPV infection. Gynecol Oncol 2001 8 : 125 127.
36. Sarian LO, Derchain SF, Pittal Dda R, Andrade LA, Morais SS, Figueiredo PG. Human papillomavirus detection by hybrid capture II and residual or recurrent high-grade squamous cervical intraepithelial neoplasia after large loop excision of the transformation zone (LLETZ). Tumori 2005 91 : 188 192.
37. Jancar N, Rakar S, Poljak M, Fujs K, Kocjan BJ, Vrtacnik-Bokal E. Efficiency of three surgical procedures in eliminating high-risk human papillomavirus infection in women with precancerous cervical lesions. Eur J Gynaecol Oncol 2006 27 : 239 242. (Pubitemid 43953417)
38. TOMBOLA Group. Cytological surveillance compared with immediate referral for colposcopy in management of women with low grade cervical abnormalities: multicentre randomised controlled trial. BMJ 2009 339 : b2546.
39. The TOMBOLA Group. Biopsy and selective recall compared to immediate large loop excision in the management of women with low-grade cervical cytology referred for colposcopy. Results from the TOMBOLA multi-centre randomised controlled trial. BMJ 2009 339 : b2548.
40. Cotton SC, Sharp L, Little J, Duncan I, Alexander L, Cruickshank ME, et al. Trial of management of borderline and other low-grade abnormal smears (TOMBOLA): trial design. Contemp Clin Trials 2006 27 : 449 471. (Pubitemid 44209242)
41. The TOMBOLA Group. Options for managing low grade cervical abnormalities detected at screening: cost effectiveness study. BMJ 2009 339 : b2549.
42. Jacobs MV, Snijders PJ, van den Brule AJ. A general primer GP5+/GP6(+)-mediated PCR-enzyme immunoassay method for rapid detection of 14 high-risk and 6 low-risk human papillomavirus genotypes in cervical scrapings. J Clin Microbiol 1997 35 : 791 795.
43. Committee for Proprietary Medicinal Products (CPMP). Committee for proprietary medicinal products (CPMP): points to consider on adjustment for baseline covariates. Stat Med 2004 23 : 701 709.
44. Segi M. Cancer Mortality for Selected Sites in 24 Countries (1950-1957).
45. NHS Cervical Screening Programme. Liquid Based Cytology (LBC): The Conversion to LBC is Now Complete.
46. Moss SM, Gray A, Marteau T, Legood R, Henstock E, Maissi E Evaluation of HPV/LBC Cervical Screening Pilot Studies. Report to the Department of Health (revised October 2004). 2004 : 1 307. [ http://www.cancerscreening.nhs.uk/ cervical/evaluation-hpv-2006feb.pdf ]. Accessed 1 December 2009.
47. Kiatpongsan S, Niruthisard S, Mutirangura A, Trivijitsilp P, Vasuratna A, Chaithongwongwatthana S, et al. Role of human papillomavirus DNA testing in management of women with atypical squamous cells of undetermined significance. Int J Gynecol Cancer 2006 16 : 262 265.
48. Andersson S, Dillner L, Elfgren K, Mints M, Persson M, Rylander E. A comparison of the human papillomavirus test and papanicolaou smear as a second screening method for women with minor cytological abnormalities. Acta Obstet Gynecol Scand 2005 84 : 996 1000. (Pubitemid 41400303)
49. Pisal N, Sindos M, Chow C, Singer A. Triage by HPV-DNA testing: is it useful in women with persistent minor smear abnormalities? Acta Obstet Gynecol Scand 2003 82 : 575 577.
50. Melnikow J, Nuovo J, Willan AR, Chan BKS, Howell LP. Natural history of cervical squamous intraepithelial lesions: a meta-analysis. Obstet Gynecol 1998 92 : 727 735.
51. Jeronimo J, Massad LS, Schiffman M, National Institutes of Health/American Society for Colposcopy and Cervical Pathology (NIH/ASCCP) Research Group. Visual appearance of the uterine cervix: correlation with human papillomavirus detection and type. Am J Obstet Gynecol 2007 1 : 47.
52. Naucler P, Ryd W, Tornberg S, Strand A, Wadell G, Elfgren K, et al. Human papillomavirus and papanicolaou tests to screen for cervical cancer. N Engl J Med 2007 357 : 1589 1597.
53. Arbyn M, Buntinx F, Van Ranst M, Paraskevaidis E, Martin-Hirsch P, Dilner J. Virologic versus cytologic triage of women with equivocal pap smears: a meta-analysis of the accuracy to detect high-grade intraepithelial neoplasia. J Natl Cancer Inst 2004 96 : 280 293. (Pubitemid 38256273)
54. Carozzi F, Cecchini S, Confortini M, Becattini V, Cariaggi MP, Pontenani G, et al. Role of P16(INK4a) expression in identifying CIN2 or more severe lesions among HPV-positive patients referred for colposcopy after abnormal cytology. Cancer 2006 108 : 119 123.
55. Giovannelli L, Capra G, Lama A, Bustinto T, Genco A, Valenti FM, et al. Atypical squamous cells of undetermined significance-favour reactive compared to atypical squamous cells of undetermined significance-favour dysplasia: association with cervical intraepithelial lesions and human papillomavirus infection. J Clin Virol 2005 33 : 281 286.
56. Carozzi FM, Confortini M, Cecchini S, Bisanzi S, Cariaggi MP, Pontenani G, et al. Triage with human papillomavirus testing of women with cytologic abnormalities prompting referral for colposcopy assessment. Cancer Cytopathol 2005 105 : 2 7.
57. Monsonego J, Pintos J, Semaille C, Beumont M, Dachez R, Zerat L, et al. Human papillomavirus testing improves the accuracy of colposcopy in detection of cervical intraepithelial neoplasia. Int J Gynecol Cancer 2006 16 : 591 598.
58. Agorastos T, Miliaras D, Lambropoulos AF, Chrisafi S, Kotsis A, Manthos A, et al. Detection and typing of human papillomavirus DNA in uterine cervices with coexistent grade I and grade III intraepithelial neoplasia: biologic progression or independent lesions? Eur J Obstet Gynecol Reprod Biol 2005 121 : 99 103.
59. Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet 2006 367 : 489 498.